Potential pharmacokinetic interactions with concurrent use of herbal medicines and a ritonavir-boosted COVID-19 protease inhibitor in low and middle-income countries.
Saved in:
| Title: | Potential pharmacokinetic interactions with concurrent use of herbal medicines and a ritonavir-boosted COVID-19 protease inhibitor in low and middle-income countries. |
|---|---|
| Authors: | Smith DJ; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, United States.; COVID-19 Response International Task Force, Centers for Disease Control and Prevention, Atlanta, GA, United States., Bi H; School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China., Hamman J; Centre of Excellence for Pharmaceutical Sciences (Pharmacen™), Faculty of Health Sciences, North-West University, Potchefstroom, South Africa., Ma X; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, United States., Mitchell C; Health and Environmental Sciences Institute, Washington, DC, United States., Nyirenda K; Department of Pharmacy, Kamuzu University of Health Sciences, Blantyre, Malawi., Monera-Penduka T; Research Unit for Safety of Herbs and Drugs, University of Zimbabwe, Harare, Zimbabwe., Oketch-Rabah H; United States Pharmacopeia, Rockville, MD, United States., Paine MF; Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, United States., Pettit S; Health and Environmental Sciences Institute, Washington, DC, United States., Pheiffer W; DSI/NWU Preclinical Drug Development Platform, Faculty of Health Sciences, North-West University, Potchefstroom, South Africa., Van Breemen RB; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, OR, United States., Embry M; Health and Environmental Sciences Institute, Washington, DC, United States. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2023 Jul 12; Vol. 14, pp. 1210579. Date of Electronic Publication: 2023 Jul 12 (Print Publication: 2023). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
